Loading organizations...
Invivo Capital is a Barcelona, Spain-based venture capital firm investing in early-stage biotechnology and life sciences companies, particularly at the intersection of AI, synthetic biology, and advanced therapies. The firm manages funds, including the €60 million Invivo Ventures, and is preparing to launch its €100 million Invivo Ventures III, providing scientific, technical, and financial expertise to support portfolio growth. Its current portfolio comprises 17 companies, with four successful exits to date, focusing on technology transfer from European opportunities. Notable portfolio companies include nLife Therapeutics and Peptomyc, with the European Investment Fund (EIF) among its key investors. Invivo Capital was founded in 2012 by Luis Pareras and Albert Ferrer. Its business model centers on raises and manages venture capital funds from private and institutional investors, including the European Investment Fund , ICO, and regional bodies, to invest in early-stage health tech companies.
Key people at Invivo Capital.
Invivo Capital was founded in 2012 by Ngozi Edozien (Founder and Managing Director).
Key people at Invivo Capital.
Invivo Capital has 4 tracked investments across 4 companies. The latest tracked deal is $12.5M Pre-Series A in Integra Therapeutics in September 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 8, 2025 | Integra Therapeutics | $12.5M Pre-Series A | — | Advent France Biotechnology, Cdti, Columbus Venture Partners, Svetoslava Georgieva, Takeda Ventures |
| Sep 1, 2025 | ARTHEx Biotech | $41.0M Series B | Laurent Higueret | Advent Life Sciences, Alta Life Sciences, Sanofi Ventures, Ysios Capital, Advent France Biotechnology, CDTI Innvierte, José Antonio Mesa, European Innovation Council, Hadean Ventures, Sound Bioventures |
| Jan 8, 2025 | Neumirna Therapeutics | $23.3M Series A | Invivo Capital | — |
| Sep 1, 2023 | Corteria Pharmaceuticals | $70.0M Series A | Rafaèle Tordjman, Erez Chimovits | Caixa Capital Risc, Faber, Kurma Partners, Roche Venture Fund, Sanofi Ventures, Fountain Healthcare Partners, Omnes Capital, V BIO Ventures |
Invivo Capital was founded in 2012 by Ngozi Edozien (Founder and Managing Director).
